Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Moleculin Biotech Inc. (MBRX)

1.19   -0.03 (-2.46%) 09-16 16:00
Open: 1.19 Pre. Close: 1.22
High: 1.22 Low: 1.18
Volume: 310,190 Market Cap: 54M
Moleculin Biotech Inc is a preclinical stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.221 - 1.227 1.227 - 1.231
Low: 1.165 - 1.174 1.174 - 1.179
Close: 1.178 - 1.191 1.191 - 1.198

Technical analysis

as of: 2019-09-16 4:30:42 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.42     One year: 1.66
Support: Support1: 1.11    Support2: 1.05
Resistance: Resistance1: 1.22    Resistance2: 1.42
Pivot: 1.14
Moving Average: MA(5): 1.18     MA(20): 1.14
MA(100): 1.18     MA(250): 1.26
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 88.21     %D(3): 84.10
RSI: RSI(14): 57.60
52-week: High: 3.15  Low: 0.78  Change(%): -27.0
Average Vol(K): 3-Month: 26055  10-Days: 18480

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
MBRX has closed below upper band by 14.7%. Bollinger Bands are 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 85 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45.20
Shares Float (M) 34.23
% Held by Insiders 23.73
% Held by Institutions 11.23
Shares Short (K) 2730
Shares Short P. Month (K)

Stock Financials

EPS -0.320
Book Value (p.s.) 0.490
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -33.8
Return on Equity (ttm) -51.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.331
Qtrly Earnings Growth
Operating Cash Flow (M) -15.12
Levered Free Cash Flow (M) -3.41

Stock Valuations

P/E -3.72
P/E Growth Ratio -0.02
P/BV 2.43
P/CF -3.56

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.